JP2017155057A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017155057A5 JP2017155057A5 JP2017116440A JP2017116440A JP2017155057A5 JP 2017155057 A5 JP2017155057 A5 JP 2017155057A5 JP 2017116440 A JP2017116440 A JP 2017116440A JP 2017116440 A JP2017116440 A JP 2017116440A JP 2017155057 A5 JP2017155057 A5 JP 2017155057A5
- Authority
- JP
- Japan
- Prior art keywords
- parvovirus
- pharmaceutical composition
- composition according
- cancer
- bcl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000125945 Protoparvovirus Species 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 239000012664 BCL-2-inhibitor Substances 0.000 claims 4
- 229940123711 Bcl2 inhibitor Drugs 0.000 claims 4
- 241000700605 Viruses Species 0.000 claims 2
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000032612 Glial tumor Diseases 0.000 claims 1
- 201000010915 Glioblastoma multiforme Diseases 0.000 claims 1
- 206010018338 Glioma Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 241000702321 Microvirus Species 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 241000283984 Rodentia Species 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 230000003013 cytotoxicity Effects 0.000 claims 1
- 231100000135 cytotoxicity Toxicity 0.000 claims 1
- 208000005017 glioblastoma Diseases 0.000 claims 1
- 201000010536 head and neck cancer Diseases 0.000 claims 1
- 208000014829 head and neck neoplasm Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 230000000306 recurrent effect Effects 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13003664.3 | 2013-07-22 | ||
| EP20130003664 EP2829284A1 (en) | 2013-07-22 | 2013-07-22 | Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016528375A Division JP6195988B2 (ja) | 2013-07-22 | 2014-07-22 | パルボウイルスにＢｃｌ−２阻害剤を併用する癌療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017155057A JP2017155057A (ja) | 2017-09-07 |
| JP2017155057A5 true JP2017155057A5 (OSRAM) | 2017-11-16 |
Family
ID=48856486
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016528375A Active JP6195988B2 (ja) | 2013-07-22 | 2014-07-22 | パルボウイルスにＢｃｌ−２阻害剤を併用する癌療法 |
| JP2017116440A Pending JP2017155057A (ja) | 2013-07-22 | 2017-06-14 | パルボウイルスおよびＢｃｌ−２阻害剤を含有する医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016528375A Active JP6195988B2 (ja) | 2013-07-22 | 2014-07-22 | パルボウイルスにＢｃｌ−２阻害剤を併用する癌療法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9889169B2 (OSRAM) |
| EP (2) | EP2829284A1 (OSRAM) |
| JP (2) | JP6195988B2 (OSRAM) |
| AU (1) | AU2014295442B2 (OSRAM) |
| CA (1) | CA2914420C (OSRAM) |
| DK (1) | DK3024491T3 (OSRAM) |
| ES (1) | ES2636768T3 (OSRAM) |
| WO (1) | WO2015010782A1 (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3069724A1 (en) * | 2015-03-19 | 2016-09-21 | Deutsches Krebsforschungszentrum | Lung cancer therapy with a rodent parvovirus |
| SG10201913331VA (en) * | 2016-03-15 | 2020-03-30 | Oryzon Genomics Sa | Combinations of lsd1 inhibitors for use in the treatment of solid tumors |
| CA3017773A1 (en) * | 2016-03-17 | 2017-09-21 | Deutsches Krebsforschungszentrum | Lung cancer therapy with a parvovirus |
| EP3225253A1 (en) | 2016-04-01 | 2017-10-04 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor |
| CN106177955B (zh) * | 2016-08-18 | 2018-03-16 | 广州威溶特医药科技有限公司 | Bcl‑xL抑制剂和溶瘤病毒在制备抗肿瘤药物中的应用 |
| CN110944647B (zh) * | 2017-05-19 | 2024-10-08 | 加利福尼亚大学董事会 | 作为调节细胞疗法的分子开关的抗体化学诱导二聚体(AbCID) |
| EP3657172A1 (en) | 2018-11-22 | 2020-05-27 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Method for predicting the clinical response of oncolytic parvovirus h1 (h-1pv) treatment in a patient suspected of suffering from cancer by measuring the expression levels of laminins and/or galectins as biomarkers in a patient´s sample |
| US20240041833A1 (en) | 2020-12-21 | 2024-02-08 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Pharmaceutical combination product comprising a protoparvovirus and an antiviral benzimidazole and uses thereof for treating cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2402138T3 (es) | 2007-12-28 | 2013-04-29 | Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts | Terapia contra el cáncer con un parvovirus combinado con quimioterapia |
| EP2366398A1 (en) | 2010-03-17 | 2011-09-21 | Deutsches Krebsforschungszentrum | Cancer therapy with a parvovirus combined with an HDAC inhibitor |
-
2013
- 2013-07-22 EP EP20130003664 patent/EP2829284A1/en not_active Withdrawn
-
2014
- 2014-07-22 JP JP2016528375A patent/JP6195988B2/ja active Active
- 2014-07-22 DK DK14752272.6T patent/DK3024491T3/en active
- 2014-07-22 WO PCT/EP2014/002001 patent/WO2015010782A1/en not_active Ceased
- 2014-07-22 CA CA2914420A patent/CA2914420C/en active Active
- 2014-07-22 ES ES14752272.6T patent/ES2636768T3/es active Active
- 2014-07-22 EP EP14752272.6A patent/EP3024491B1/en active Active
- 2014-07-22 AU AU2014295442A patent/AU2014295442B2/en active Active
-
2015
- 2015-12-07 US US14/960,608 patent/US9889169B2/en active Active
-
2017
- 2017-06-14 JP JP2017116440A patent/JP2017155057A/ja active Pending
- 2017-12-28 US US15/856,241 patent/US10406185B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017155057A5 (OSRAM) | ||
| IL285782A (en) | Compounds, compositions, and methods for treating disease | |
| JP2020503891A5 (OSRAM) | ||
| JP2016104790A5 (OSRAM) | ||
| EA201790476A1 (ru) | Аминопиридилоксипиразольные соединения | |
| WO2017189964A3 (en) | Compositions for the treatment of disease | |
| JP2016153410A5 (OSRAM) | ||
| MX2019000864A (es) | Activadores de histona acetiltransferasa y sus composiciones y usos. | |
| NZ738018A (en) | Adenoassociated virus vectors for the treatment of mucopolysaccharidoses | |
| JP2014129360A5 (OSRAM) | ||
| EA201792487A1 (ru) | Композиции гидроксипропил-бета-циклодекстринов и способы | |
| JP2017501848A5 (OSRAM) | ||
| JP2013541586A5 (OSRAM) | ||
| JP2016540015A5 (OSRAM) | ||
| JP2017518260A5 (OSRAM) | ||
| JP2016520594A5 (OSRAM) | ||
| WO2018071822A3 (en) | Antibodies that bind zika virus envelope protein and uses thereof | |
| JP2017531686A5 (OSRAM) | ||
| RU2016131363A (ru) | ПРОИЗВОДНЫЕ АРИЛСУЛЬТАМА В КАЧЕСТВЕ МОДУЛЯТОРОВ ОРФАННОГО РЕЦЕПТОРА γ, СВЯЗАННОГО С РЕТИНОЕВОЙ КИСЛОТОЙ | |
| EP4484953A3 (en) | Enantiomers of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine (anavex2-73) and use thereof in the treatment of alzheimer's disease and other disorders modulated by the sigma 1 receptor | |
| HK1251998A1 (zh) | 佐米曲普坦肺部给药粉 | |
| WO2020123330A3 (en) | Anti-alpha-synuclein antibodies and uses thereof | |
| WO2016106284A3 (en) | Creatine prodrugs, compositions and methods of use thereof | |
| JP2020531778A5 (OSRAM) | ||
| JP2009505991A5 (OSRAM) |